Dose-dependent biotransformation of arsenite in rats - Not S-adenosylmethionine depletion impairs arsenic methylation at high dose

Toxicology

Volumn 183, Issue 1-3, 2003, Pages 77-91

  Csanaky, Iván ^a   Németi, Balázs ^a   Gregus, Zoltán ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Arsenite; ATP; Excretion; Glutathione; Methylation; S adenosylmethionine

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE TRIPHOSPHATE; ARSENIC TRIOXIDE; GLUTATHIONE; METHYLTRANSFERASE; S ADENOSYLMETHIONINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE; BILIARY EXCRETION; BIOTRANSFORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENERGY; ENZYME INHIBITION; LIVER LEVEL; MALE; METHYLATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; URINALYSIS; URINARY EXCRETION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ARSENITES; BILE; BIOTRANSFORMATION; CACODYLIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; KIDNEY; LIVER; MALE; METHYLATION; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; RATS; RATS, WISTAR; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE;

EID: 0037291506     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(02)00444-4     Document Type: Article

References (54)

1. Anundi I., Hogberg J., Vahter M. GSH release in bile as influenced by arsenite. FEBS Lett. 145:1982;285-288.
2. Aposhian H.V., Gurzau E.S., Le X.C., Gurzau A., Healy S.M., Lu X., Ma M., Yip L., Zakharyan R.A., Maiorino R.M., Dart R.C., Tircus M.G., Gonzalez-Ramirez D., Morgan D.L., Avram D., Aposhian M.M. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 13:2000;693-697.
3. Atkinson D.E. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry. 7:1968;4030-4034.
4. Buchet J.P., Lauwerys R., Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsonate in man. Int. Arch. Occup. Environ. Health. 48:1981;71-79.
5. Buchet J.P., Lauwerys R. Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man. Arch. Toxicol. 57:1985;125-129.
6. Buchet J.P., Lauwerys R. Study of factors influencing the in vivo methylation of inorganic arsenic in rats. Toxicol. Appl. Pharmacol. 91:1987;65-74.
7. Csanaky I., Gregus Z. Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats. Toxicol. Sci. 63:2001;29-36.
8. Csanaky I., Gregus Z. Species variations in the biliary and urinary excretion of arsenate, arsenite and their metabolites. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 131:2002;355-365.
9. Cullen W.R. The metabolism of methylarsine oxide and sulfide. Appl. Organometal. Chem. 3:1989;71-78.
10. Cullen W.R., McBride B.C., Reglinski J. The reaction of methylarsenicals with thiols: some biological implications. J. Inorg. Biochem. 21:1984;179-194.
11. De Kimpe J., Cornelis R., Wittevrongel L., Vanholder R. Dose dependent changes in 74As-arsenate metabolism of Flemish Giant rabbits. J. Trace Elem. Med. Biol. 12:1999;193-200.
12. Del Razo L.M., Garcia-Vargas G.G., Vargas H., Albores A., Gonsebatt M.E., Montero R., Ostrosky-Wegman P., Kelsh M., Cebrián M.E. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch. Toxicol. 71:1997;211-217.
13. Dietrich C.G., Ottenhoff R., de Waart D.R., Oude Elferink R.P. Role of MRP2 and GSH in intrahepatic cycling of toxins. Toxicology. 167:2001;73-81.
14. Dills R.L., Klaassen C.D. An isocratic reverse-phase high-performance liquid chromatographic assay for adenine nucleotides in rat liver. J. Pharmacol. Methods. 14:1985;189-197.
15. Fanton L., Duperret S., Guillaumee F., Miras A., Vallon J.J., Malicier D. Fatal rhabdomyolysis in arsenic trioxide poisoning. Hum. Exp. Toxicol. 18:1999;640-641.
16. Georis B., Cardenas A., Buchet J.P., Lauwerys R.R. Inorganic arsenic methylation by rat tissue slices. Toxicology. 63:1990;73-84.
17. Goering P.L., Aposhian H.V., Mass M.J., Cebrián M., Beck B.D., Waalkes M.P. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol. Sci. 49:1999;5-14.
18. Gregus Z., Gyurasics Á., Csanaky I. Biliary and urinary excretion of inorganic arsenic. Monomethylarsonous acid as a major biliary metabolite in rats. Toxicol. Sci. 56:2000;18-25.
19. Gyurasics Á., Varga F., Gregus Z. Effect of arsenicals on biliary excretion of glutathione and xenobiotics undergoing conjugation with glutathione. Biochem. Pharmacol. 41:1991;937-944.
20. Gyurasics Á., Varga F., Gregus Z. Glutathione-dependent biliary excretion of arsenic. Biochem. Pharmacol. 42:1991;465-468.
21. Hoffman J.L. The rate of transmethylation in mouse liver as measured by trapping S-adenosylhomocysteine. Arch. Biochem. Biophys. 205:1980;132-135.
22. Hopenhayn-Rich C., Smith A.H., Goeden H.M. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ. Res. 60:1993;161-177.
23. Huff J., Chan P., Nyska A. Is the human carcinogen arsenic carcinogenic to laboratory animals? Toxicol. Sci. 55:2000;17-23.
24. Kala S.V., Neely M.W., Kala G., Prater C., Atwood D.W., Rice J.R., Lieberman W. The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275:2000;33404-33408.
25. Klaassen C.D. Biliary excretion of arsenic in rats, rabbits and dogs. Toxicol. Appl. Pharmacol. 29:1974;447-457.
26. Knowles F.C., Benson A.A. The biochemistry of arsenic. Trends Biochem. Sci. 8:1983;178-180.
27. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Toxicol. 14:2001;371-378.
28. 75As) arsenite in mice and rabbits. Chem. Biol. Interact. 50:1984;49-57.
29. Marafante E., Vahter M., Norin H., Envall J., Sandström M., Christakopoulos A., Ryhage R. Biotransformation of dimethylarsinic acid in mouse, hamster and man. J. Appl. Toxicol. 7:1987;111-117.
30. 3. Its significance for duration of BAL therapy. Clin. Toxicol. 18:1981;1067-1075.
31. Ohnishi K., Yoshida H., Shigeno K., Nakamura S., Fujisawa S., Naito K., Shinjo K., Fujita Y., Matsui H., Takeshita A., Sugiyama S., Satoh H., Terada H., Ohno R. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann. Intern. Med. 133:2000;881-885.
32. Petrick J.S., Ayala-Fierro F., Cullen W.R., Carter D.E., Aposhian H.V. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163:2000;203-207.
33. Petrick J.S., Jagadish B., Mash E.A., Aposhian H.V. Monomethylarsonous acid (MMA(III)) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14:2001;651-656.
34. 3. Arch. Toxicol. 63:1989;419-422.
35. Roses O.E., García Fernández J.C., Villaamil E.C., Camussa N., Minetti S.A., Martinez de Marco M., Quiroga P.N., Rattay P., Sassone A., Valle Garecca B.S., López C.M., Olmos V., Pazos P., Piñeiro A., Rodriguez Lenci J. Mass poisoning by sodium arsenite. J. Toxicol. Clin. Toxicol. 29:1991;209-213.
36. She Q.B., Nagao I., Hayakawa T., Tsuge H. A simple HPLC method for the determination of S-adenosylmethionine and S-adenosylhomocysteine in rat tissues: the effect of vitamin B6 deficiency on these concentrations in rat liver. Biochem. Biophys. Res. Commun. 205:1994;1748-1754.
37. Soignet S.L., Maslak P., Wang Z.G., Jhanwar S., Calleja E., Dardashti L.J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D.A., Pandolfi P.P., Warrel R.P. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New Eng. J. Med. 339:1998;1341-1348.
38. Soignet S.L., Frankel S.R., Douer D., Tallman M.S., Kantarjian H., Calleja E., Stone R.M., Kalaycio M., Scheinberg D.A., Steinherz P., Sievers E.L., Coutre S., Dahlberg S., Ellison R., Warrell R.P. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J. Clin. Oncol. 19:2001;3852-3860.
39. Styblo M., Delnomdedieu M., Thomas D.J. Mono- and dimethylation of arsenic in rat liver cytosol in vitro. Chem. Biol. Interact. 99:1996;147-164.
40. Styblo M., Del Razo M.L., LeCluyse E.L., Hamilton G.A., Wang C., Cullen W.R., Thomas D.J. Metabolism of arsenic in primary cultures of human and rat hepatocytes. Chem. Res. Toxicol. 12:1999;560-565.
41. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74:2000;289-299.
42. Thompson D.J. A chemical hypothesis for arsenic methylation in mammals. Chem. Biol. Interact. 88:1993;89-114.
43. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27:1969;502-522.
44. Unnikrishnan D., Dutcher J.P., Varshneya N., Lucariello R., Api M., Garl M., Wiernik P.H., Chiaramida S. Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood. 97:2001;1514-1516.
45. Vahter M. Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. Environ. Res. 25:1981;286-293.
46. Vahter M. Metabolism of arsenic. Fowler B.A. Biological and Environmental Effects of Arsenic. 1983;170-197 Elsevier Science Publishers, New York.
47. Vahter M., Concha G. Role of metabolism in arsenic toxicity. Pharmacol. Toxicol. 89:2001;1-5.
48. 74As-arsenite. Arch. Toxicol. 51:1982;65-77.
49. Vahter M., Marafante E. In vivo methylation and detoxication of arsenic. Glocking F., Craig P.J. The Biological Alkylation of Heavy Elements. 1988;105-119 Royal Society of Chemistry, London.
50. Wei X., Brockhoff-Schwegel C.A., Creed J.T. Application of sample pre-oxidation of arsenite in human urine prior to speciation via on-line photo-oxidation with membrane hydride generation and ICP-MS detection. Analyst. 125:2000;1215-1220.
51. Westervelt P., Brown R.A., Adkins D.R., Khoury H., Curtin P., Hurd D., Luger S.M., Ma M.K., Ley T.J., DiPersio J.F. Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood. 98:2001;266-271.
52. Yamauchi H., Yamamura Y. Metabolism and excretion of orally administered dimethylarsinic acid in the hamster. Toxicol. Appl. Pharmacol. 74:1984;134-140.
53. Yamauchi H., Yamato N., Yamamura Y. Metabolism and excretion of orally and intraperitoneally administered methylarsonic acid in the hamster. Bull. Environ. Contam. Toxicol. 40:1988;280-286.
54. Zakharyan R.A., Ayala-Fierro F., Cullen W.R., Carter D.M., Aposhian H.V. Enzymatic methylation of arsenic compounds. VII. Monomethylarsonous acid (MMAIII) is the substrate for MMA methyltransferase of rabbit liver and human hepatocytes. Toxicol. Appl. Pharmacol. 158:1999;9-15.